Kailera Therapeutics has filed for an initial public offering (IPO), ​hoping to whet investor appetites with its pipeline of drug candidates for weight loss. Waltham, Massachusetts-based Kailera has ...
A major UK-led study has found that undiagnosed heart failure (HF) can be detected in people with high-risk diabetes using a simple, community-based care pathway. The TARTAN-HF trial, run by the ...
The EMA's human medicines committee has recommended approval of Amgen's bispecific T-cell engager (BiTE) – Imdylltra – as a second-line treatment option for extensive-stage small cell lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results